These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 18288959)
1. Cyclic metabolites: chemical and biological considerations. Erve JC Curr Drug Metab; 2008 Feb; 9(2):175-88. PubMed ID: 18288959 [TBL] [Abstract][Full Text] [Related]
2. The biotransformation of nitrogen containing xenobiotics to lactams. Vickers S; Polsky SL Curr Drug Metab; 2000 Dec; 1(4):357-89. PubMed ID: 11465044 [TBL] [Abstract][Full Text] [Related]
3. 3-(2,6-Xylyl)-5-methylhydantoin--a metabolite or a metabonate of tocainide in rats. Venkataramanan R; Axelson JE Xenobiotica; 1981 Apr; 11(4):259-65. PubMed ID: 6795837 [TBL] [Abstract][Full Text] [Related]
5. Topics in Xenobiochemistry: do metabolic pathways exist for xenobiotics? The micro-metabolism hypothesis. Wilson ID; Nicholson JK Xenobiotica; 2003 Sep; 33(9):887-901. PubMed ID: 14514439 [TBL] [Abstract][Full Text] [Related]
6. Measurement of urinary metabolites of xenobiotics as a non-invasive technique in toxicology. Breimer DD Arch Toxicol Suppl; 1982; 5():162-78. PubMed ID: 6954894 [TBL] [Abstract][Full Text] [Related]
7. On the diversity of oxidative bioactivation reactions on nitrogen-containing xenobiotics. Kalgutkar AS; Dalvie DK; O'Donnell JP; Taylor TJ; Sahakian DC Curr Drug Metab; 2002 Aug; 3(4):379-424. PubMed ID: 12093357 [TBL] [Abstract][Full Text] [Related]
8. [Xenobiotic toxicity prediction combined with xenobiotic metabolism prediction in the human body]. Rudik AV; Dmitriev AV; Lagunin AA; Ivanov SM; Filimonov DA; Poroikov VV Biomed Khim; 2019 Feb; 65(2):114-122. PubMed ID: 30950816 [TBL] [Abstract][Full Text] [Related]
9. Chemical metabolite synthesis and profiling: Mimicking in vivo biotransformation reactions. Chhatrapati Bisen A; Nashik Sanap S; Agrawal S; Biswas A; Sankar Bhatta R Bioorg Chem; 2023 Oct; 139():106722. PubMed ID: 37453238 [TBL] [Abstract][Full Text] [Related]
10. Phase II enzymes and bioactivation. Hinson JA; Forkert PG Can J Physiol Pharmacol; 1995 Oct; 73(10):1407-13. PubMed ID: 8748931 [TBL] [Abstract][Full Text] [Related]
11. Drug metabolism for the perplexed medicinal chemist. Testa B Chem Biodivers; 2009 Nov; 6(11):2055-70. PubMed ID: 19937836 [TBL] [Abstract][Full Text] [Related]
12. Drug bioactivation and protein adduct formation in the pathogenesis of drug-induced toxicity. Park BK; Laverty H; Srivastava A; Antoine DJ; Naisbitt D; Williams DP Chem Biol Interact; 2011 Jun; 192(1-2):30-6. PubMed ID: 20846520 [TBL] [Abstract][Full Text] [Related]
13. [THE SYSTEM OF XENOBIOTICS BIOTRANSFORMATION OF HELMINTHS. RESEMBLANCE AND DIFFERENSES FROM SIMILAR HOST SYSTEMS (REWEW)]. Smirnov LP; Borvinskaya EV; Suhovskaya IV Parazitologiia; 2016; 50(6):432-45. PubMed ID: 29215225 [TBL] [Abstract][Full Text] [Related]
14. Metatox - Web application for generation of metabolic pathways and toxicity estimation. Rudik A; Bezhentsev V; Dmitriev A; Lagunin A; Filimonov D; Poroikov V J Bioinform Comput Biol; 2019 Feb; 17(1):1940001. PubMed ID: 30866738 [TBL] [Abstract][Full Text] [Related]
15. Metabolism of tocainide in the rat. Venkataramanan R; Abbott FS; Axelson JE J Pharm Sci; 1982 May; 71(5):491-4. PubMed ID: 6808112 [TBL] [Abstract][Full Text] [Related]
16. Selection of new chemical entities with decreased potential for adverse drug reactions. Park KB; Dalton-Brown E; Hirst C; Williams DP Eur J Pharmacol; 2006 Nov; 549(1-3):1-8. PubMed ID: 16979156 [TBL] [Abstract][Full Text] [Related]
17. Role of cyclic tertiary amine bioactivation to reactive iminium species: structure toxicity relationship. Mašič LP Curr Drug Metab; 2011 Jan; 12(1):35-50. PubMed ID: 21222587 [TBL] [Abstract][Full Text] [Related]
18. Enzymatic oxidative activation and transformation of the antitumor agent mitoxantrone. Kolodziejczyk P; Reszka K; Lown JW Free Radic Biol Med; 1988; 5(1):13-25. PubMed ID: 3254299 [TBL] [Abstract][Full Text] [Related]
19. GLORYx: Prediction of the Metabolites Resulting from Phase 1 and Phase 2 Biotransformations of Xenobiotics. de Bruyn Kops C; Šícho M; Mazzolari A; Kirchmair J Chem Res Toxicol; 2021 Feb; 34(2):286-299. PubMed ID: 32786543 [TBL] [Abstract][Full Text] [Related]